{"name":"Clorazepate","slug":"clorazepate","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Clorazepic acid","Cchlorazepic acid","7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid","4306-cb free acid","Abbott-35616 free acid","1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-","Tranxilene","Tencilan","Mendon","245-926-8"],"brands":[],"scraped":true,"has_structure":true,"cid":2809,"classes":[{"name":"depressant","href":"/class/depressant"},{"name":"opioid","href":"/class/opioid"}],"families":[{"name":"aniline","href":"/substituted/aniline"},{"name":"benzodiazepine","href":"/substituted/benzodiazepine"}],"physical":[{"label":"Molecular mass","value":"314.72 g/mol","copyable":false},{"label":"Appearance","value":"FINE, LIGHT-YELLOW CRYSTALLINE POWDER; AQ SOLN ARE CLEAR, LIGHT-YELLOW","copyable":false},{"label":"Melting point","value":"228-235°C","copyable":false},{"label":"Solubility","value":"Very soluble","copyable":false},{"label":"Predicted LogP","value":"3.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>16</sub>H<sub>11</sub>ClN<sub>2</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid","copyable":true},{"label":"SMILES","value":"C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O","copyable":true},{"label":"InChI","value":"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)","copyable":true},{"label":"InChIKey","value":"XDDJGVMJFWAHJX-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"23887-31-2","copyable":true},{"label":"UNII","value":"D51WO0G0L4","copyable":true},{"label":"PubChem CID","value":"2809","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"48 hours","copyable":false},{"label":"Metabolism","value":"Hepatic","copyable":false},{"label":"Excretion","value":"Renal","copyable":false},{"label":"Routes of administration","value":"Oral","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Rat",[{"kind":"LD50","organism":"Rat","route":"Oral","dose":"1320 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[{"name":"(R)-Clorazepate","href":"/substance/%28r%29-clorazepate"},{"name":"(S)-Clorazepate","href":"/substance/%28s%29-clorazepate"}],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[{"name":"Anticonvulsants","id":"M0001382"},{"name":"Anti-Anxiety Agents","id":"M0021771"},{"name":"GABA Modulators","id":"M0028093"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Clorazepate is a benzodiazepine with depressant effects on the central nervous system. Benzodiazepines are able to enhance the binding of gamma-aminobutyric acid (GABA) to the GABA type A (GABA-A) receptor by binding to a region in the extracellular domain found at the interface between the alpha (α) and gamma (γ) subunits of the GABA-A receptor. The interaction of GABA and the GABA-A receptor promotes channel opening, leading to an increased chloride influx. Consequently, the use of benzodiazepines, such as clorazepate, leads to neuronal hyperpolarization.","side_effects":{"drug_id":2809,"drug_name":"clorazepate","url":"https://sideeffects.embl.de/drugs/2809/pt","atc_codes":[],"side_effects":[{"name":"Ataxia","cui":"C0004134"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Diplopia","cui":"C0012569"},{"name":"Dizziness","cui":"C0012833"},{"name":"Somnolence","cui":"C2830004"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Headache","cui":"C0018681"},{"name":"Irritability","cui":"C0022107"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Tremor","cui":"C0040822"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Dysarthria","cui":"C0013362"},{"name":"Blood pressure systolic decreased","cui":"C0277885"},{"name":"Vision blurred","cui":"C0344232"},{"name":"Haematocrit decreased","cui":"C0744727"},{"name":"Insomnia","cui":"C0917801"}],"indications":[{"name":"Alcohol withdrawal syndrome","cui":"C0236663"},{"name":"Anxiety","cui":"C0003467"},{"name":"Anxiety disorder","cui":"C0003469"},{"name":"Epilepsy","cui":"C0014544"},{"name":"Partial seizures","cui":"C0751495"},{"name":"Tension","cui":"C0233494"}]},"effects":{"groups":[["Physical Effects",["Constipation","Cough suppression","Difficulty urinating","Itchiness","Nausea","Pain relief","Pupil constriction","Respiratory depression","Sedation","Stomach cramp"]],["Cognitive Effects",["Anxiety suppression","Cognitive euphoria","Compulsive redosing","Increased music appreciation","Thought deceleration"]],["Visual Effects",["Double vision"]]]},"usernotes":[{"user":"bonzi","user_slug":"bonzi","external":false,"note":{"substance":"Clorazepate","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Prescription only/Anlage III","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class C","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Clorazepate"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/2809"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q418850"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00628"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1213252"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A3761"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=23887-31-2"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014766"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C06921"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID20863674"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Clorazepate"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/D51WO0G0L4"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/2809/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 2809, Clorazepate. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/2809>https://pubchem.ncbi.nlm.nih.gov/compound/2809</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Clorazepate. UNII: D51WO0G0L4. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/D51WO0G0L4>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/D51WO0G0L4</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 09:22:07","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 09:22:03","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 09:22:03","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 09:22:04","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 09:22:03","note":"hmdb.ca refused automated access to HMDB0014766"},{"source":"kegg","status":"missing","fetched_at":"2026-11-20 09:22:07","note":"no KEGG DRUG entry"},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 09:22:02","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 09:22:03","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 09:22:04","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 09:22:03","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 09:22:04","note":null}],"description":"Clorazepate is a depressant, opioid substance."}